Diseases and injuries can severely affect the functions of the central and peripheral nervous systems as well as the sensory organs. To develop novel therapeutic approaches – gene therapy, optogenetics, bioactive molecules, diagnostic tools, imaging techniques, or implants, among others – the Fondation Bertarelli has donated CHF 5 million to create a Catalyst Fund. This fund is designed to foster innovative research and the development of life-saving treatments for diseases (including rare diseases) affecting the brain, the spinal cord, the peripheral nervous system, and the sensory organs.

The call is open to one or more applicants from academic institutions of Western Switzerland (Bern, Fribourg, Geneva, Jura, Neuchâtel, Valais, Vaud), with preferably some components of the project being based at Campus Biotech.  The call is also open to applicants from academic institutions in the rest of Switzerland, Europe (including the United Kingdom), and the Middle East, provided some components of the project are based at Campus Biotech (no less than 50% of the costs charged on the project, including the use of technological platforms).


Applications are due by 1 June 2021 (17:00 CEST).  Apply here!